Related Experiment Video

Updated: Jul 16, 2026

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
11:11

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach

Published on: February 21, 2019

Calcium/calmodulin-dependent kinase II plays an important role in prostate cancer cell survival

Oskar W Rokhlin1, Agshin F Taghiyev, K Ulrich Bayer

  • 1Department of Pathology, University of Iowa, Iowa City, Iowa 52242, USA. oskar-rokhlin@uiowa.edu

Cancer Biology & Therapy
|March 28, 2007
PubMed

Insights

Androgen receptor (AR) knockdown in prostate cancer activates calcium/calmodulin-dependent kinase II (CaMKII). This CaMKII activation promotes cancer cell survival and progression, suggesting it as a therapeutic target.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Signaling

Background:

  • Androgen receptor (AR) is crucial for prostate cancer cell survival.
  • PI3K/Akt pathway is a known regulator of cell survival in cancer.

Purpose of the Study:

  • Investigate the role of calcium/calmodulin-dependent kinase II (CaMKII) in prostate cancer survival.
  • Elucidate the relationship between AR activity and CaMKII signaling.
  • Determine if CaMKII contributes to androgen-independent prostate cancer progression.

Main Methods:

  • siRNA-mediated knockdown of AR expression.
  • Analysis of Akt activation and its mediation by CaMKII.
  • Gene expression analysis of CaMKII isoforms (beta, gamma, delta).
  • Assessment of apoptosis resistance and cell growth under various inhibitory conditions.

Main Results:

  • AR knockdown induces PI3K-independent Akt activation via CaMKII.
  • Prostate cancer cells express CaMKII beta, gamma, and delta genes, regulated by AR activity.
  • AR inhibition leads to increased CaMKII activity and gene expression.
  • CaMKII overexpression confers resistance to apoptosis and promotes cell growth, even in steroid-free conditions.

Conclusions:

  • There is a cross-talk between AR- and CaMKII-mediated pathways in prostate cancer.
  • CaMKII plays a significant role in prostate cancer cell survival during androgen ablation.
  • CaMKII facilitates prostate cancer progression to an androgen-independent state, indicating its potential as a therapeutic target.

Related Concept Videos

Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...